Nov 17, 2021

A Glass-Half-Full Approach to Lung Cancer in the McMahon Lab

Martin McMahon, PhD, and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.

Oct 13, 2021

Huntsman Cancer Institute Researcher Receives Grant to Study Pediatric Proton Therapy

Huntsman Cancer Institute physician and researcher Matthew Poppe, MD, received a National Cancer Institute grant to study side effects of different types of radiation—proton therapy and traditional radiation therapy—in the treatment of pediatric patients.

Sep 21, 2021

Talks with Docs: Douglas Sborov, Multiple Myeloma Director at HCI

Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful and how a Robin Williams character resonates with him in this latest Talks with Docs.

Jul 28, 2021

Huntsman Cancer Institute Announces Howard Colman, MD, PhD, as Experimental Therapeutics Program Co-Leader

Huntsman Cancer Institute at the University of Utah announced the appointment of Howard Colman, MD, PhD, as the new co-leader of the Experimental Therapeutics Program. Colman is a physician-scientist at HCI, where he holds Jon M. Huntsman Presidential Professorship, and serves as a professor of neurosurgery at the U of U.

May 28, 2021

Six New Cancer Research Fellows Announced by 5 For The Fight

Six new cancer researchers will receive funding through the 5 For The Fight Cancer Research Fellowship, which aims to bring innovative ideas and new ways of thinking to eradicate cancer.

May 21, 2021

Innovative National Clinical Trials in Breast Cancer and Hematologic Cancers Open at Huntsman Cancer Institute

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.

May 10, 2021

Huntsman Cancer Institute Congratulates Faculty on Recent Academic Honors

Huntsman Cancer Institute recognizes new and renewed endowed chairs, along with the distinguished professorship of faculty. Endowed chairs play an important role in creating a partnership between donors and researchers. Distinguished professors are recognized for academic achievements and dedication to teaching.

Apr 01, 2021

Banding Together to Advance Scientific Progress

When cancer researchers from different disciplines work together, they gain new insights into how cancer begins and how it can be treated. HCI is committed to providing an atmosphere where ideas can be created, cultivated, and shared. Here are some examples of how HCI scientists are collaborating to accelerate progress in cancer research.